| Description | BBT enhances glucose-stimulated insulin secretion (GSIS) in compromised conditions, demonstrates anti-hyperglycemia effects, and shields β-cells from cytokine- or streptozotocin (STZ)-triggered apoptosis in type 2 diabetes models. Its mechanism of action involves the cAMP/PKA and long-lasting (L-type) voltage-dependent Ca2+ channel/CaMK2 pathways [1]. |
| molecular weight | 386.26 |
| Molecular formula | C18H12BrNO2S |
| CAS | 445000-45-3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |